ReviewBJR artificial intelligence2025
Artificial intelligence-powered personalized patient dosimetry in CT.
Review in BJR artificial intelligence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Advanced X-ray imaging techniques have increased the importance of patient dosimetry, requiring better dose assessment methods and improved dose management strategies to optimize imaging protocols, resulting in diagnostic information obtained with the lowest possible dose to the patient. This review explores the potential of artificial intelligence (AI) in CT dosimetry. Using machine learning models, trained with extensive data from personalized Monte Carlo dosimetry, AI significantly enhances the dosimetry process by providing accurate, rapid dose assessments. It automates organ segmentation from CT images, a critical and traditionally time-consuming step, enabling precise estimation of organ doses. AI's ability to predict dose distributions with high accuracy facilitates the seamless integration of personalized dosimetry into clinical workflows, promising improved patient safety and optimized radiation dose management. Additionally, AI-driven approaches offer substantial advancements over conventional methodologies, which often face challenges such as prolonged computation times and labour-intensive manual processes. Despite these advancements, challenges hinder the widespread adoption of AI in CT dosimetry. These include potential biases in training data and the need for robust validation to ensure accuracy across diverse patient populations and imaging conditions. Addressing these challenges is essential for realizing the full potential of AI-powered dosimetry in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.